BioInvent International
BioInvent International is a Sweden-based biotechnology company running 4 late-stage cancer trials of BI-1607, Ipilimumab (YervoyTM and BI-1910 in melanoma, uveal melanoma and non-small-cell lung cancer.
Overview
BioInvent International, based in Lund, Sweden, is a biotechnology company. BioInvent International is a clinical-stage company that discovers and develops antibodies for cancer immunotherapy, using its proprietary F.I.R.S.T. platform and n-CoDeR antibody library. On ClinicalTrials.gov it is the lead sponsor of 4 recruiting or active phase 2 and phase 3 interventional cancer trials, testing BI-1607, Ipilimumab (YervoyTM, BI-1910, BI1206 and BI-1808 in melanoma, uveal melanoma, non-small-cell lung cancer, hepatocellular carcinoma and ovarian cancer. The largest, NCT04219254 (A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours), plans to enrol 197 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyiOnctura
Shares Uveal melanoma, Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyAura Biosciences
Shares Uveal melanoma, Melanoma and the tag ctgov-sponsor.
- CompanyHaihe Biopharma
Shares Peripheral T-cell lymphomas (including cutaneous T-cell lymphoma), Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyNanjing Leads Biolabs
Shares Hepatocellular carcinoma, Ovarian cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyCatalYm
Shares Hepatocellular carcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyKrystal Biotech
Shares Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanymAbxience Research S.L.
Shares Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMultitude Therapeutics
Shares Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.